A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing. [electronic resource]
Producer: 20160523Description: 79-87 p. digitalISSN:- 1663-2826
- Body Height -- drug effects
- Bone Development -- drug effects
- Child
- Child, Preschool
- Cost-Benefit Analysis
- Dose-Response Relationship, Drug
- Female
- Growth Disorders -- drug therapy
- Human Growth Hormone -- administration & dosage
- Humans
- Male
- Parents
- Precision Medicine
- Recombinant Proteins -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.